| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 424 |
| 1 | ETANERCEPT | 369 |
| 2 | METHOTREXATE | 360 |
| 3 | ADALIMUMAB | 316 |
| 4 | ABATACEPT | 236 |
| 5 | HYDROXYCHLOROQUINE SULFATE | 211 |
| 6 | PREDNISONE | 211 |
| 7 | TOCILIZUMAB | 197 |
| 8 | LEFLUNOMIDE | 192 |
| 9 | RITUXIMAB | 192 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 56 | 0.0096 |
| 1 | GOLIMUMAB | 115 | 0.0091 |
| 2 | ANAKINRA | 97 | 0.0057 |
| 3 | ERGOCALCIFEROL | 163 | 0.0055 |
| 4 | FOSCARBIDOPA/FOSLEVODOPA | 45 | 0.0051 |
| 5 | CLINDAMYCIN PHOSPHATE | 22 | 0.0040 |
| 6 | VALPROATE SODIUM | 80 | 0.0038 |
| 7 | HUMAN IMMUNOGLOBULIN G | 66 | 0.0032 |
| 8 | ENTACAPONE | 13 | 0.0031 |
| 9 | KETOPROFEN | 35 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 464 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 428 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 358 |
| 3 | Corticosteroid [EPC] | 332 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 293 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 236 |
| 6 | Benzodiazepine [EPC] | 219 |
| 7 | Vitamin C [EPC] | 218 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 200 |
| 9 | Vitamin B12 [EPC] | 193 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lysosomal beta Glucuronidase [EPC] | 1 | 0.0156 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 97 | 0.0057 |
| 3 | Provitamin D2 Compound [EPC] | 163 | 0.0055 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 22 | 0.0044 |
| 5 | Human Immunoglobulin G [EPC] | 69 | 0.0033 |
| 6 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 2 | 0.0022 |
| 7 | Nonergot Dopamine Agonist [EPC] | 33 | 0.0021 |
| 8 | Sulfonamide Antibacterial [EPC] | 8 | 0.0020 |
| 9 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |